Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Dose-escalation Study
100%
Allogeneic
100%
Ischemic Heart Failure
100%
Mesenchymal Precursor Cells
100%
Cardiac Death
21%
Heart Failure Patients
14%
Chronic Heart Failure
14%
Cell Injection
14%
Myocardial Infarction
7%
Phase II Trial
7%
Heart Failure
7%
Immune Response
7%
All-cause Mortality
7%
Antibody Test
7%
High Dose
7%
Heart Failure Hospitalization
7%
Clinical Events
7%
Adverse Events
7%
Large Animal Model
7%
Survival Probability
7%
Cardiac Events
7%
Left Ventricular Function
7%
Kaplan-Meier
7%
Myocardial Revascularization
7%
Free Probability
7%
Transendocardial
7%
Transendocardial Injection
7%
Major Adverse Cardiac Events
7%
Nursing and Health Professions
Congestive Heart Failure
100%
Injection
50%
Heart Death
50%
Accident Prevention
50%
Imaging
16%
Heart Infarction
16%
Cardiac Event
16%
Post Hoc Analysis
16%
Vascular Guide Wire
16%
Drug Megadose
16%
Survival Rate
16%
Adverse Event
16%
All Cause Mortality
16%
Major Adverse Cardiac Event
16%
Revascularization
16%
Efficacy
16%
Medicine and Dentistry
Precursor
100%
Congestive Heart Failure
100%
Injection
21%
Heart Death
21%
Immune Response
7%
All Cause Mortality
7%
Drug Megadose
7%
Revascularization
7%
Adverse Event
7%
Myocardial Infarction
7%
Survival Rate
7%
Post-Hoc Analysis
7%
Major Adverse Cardiac Event
7%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Heart Death
50%
Heart Infarction
16%
All Cause Mortality
16%
Adverse Event
16%
Survival Rate
16%
Major Adverse Cardiac Event
16%
Biochemistry, Genetics and Molecular Biology
Precursor
100%
Animal Models
7%
Immune Response
7%
Drug Megadose
7%
Survival Rate
7%
All Cause Mortality
7%
Immunology and Microbiology
Precursor
100%
Immune Response
7%
Drug Megadose
7%
Survival Rate
7%
All Cause Mortality
7%
Revascularization
7%